Published in Heart Rhythm on October 30, 2014
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Biomarkers in heart failure. N Engl J Med (2008) 5.20
Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation (2001) 3.15
Clinical markers of organ dysfunction associated with increased 1-year mortality post-implantable cardioverter defibrillator implantation. Europace (2012) 2.65
Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm (2011) 1.80
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol (2000) 1.64
Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace (2009) 1.55
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc (2013) 1.30
Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. Am Heart J (2006) 1.23
Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J (2004) 1.15
Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol (2007) 1.12
Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation (2008) 1.03
Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score. Europace (2013) 0.95
Effect of renal function on survival after implantable cardioverter defibrillator placement. Am J Cardiol (2010) 0.88
Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators. Qual Life Res (2010) 0.88
Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure. Clin Invest Med (2005) 0.82
High-sensitivity cardiac troponin T predicts non-cardiac mortality in heart failure. Circ J (2014) 0.80
Predictors of early mortality in patients age 80 and older receiving implantable defibrillators. Pacing Clin Electrophysiol (2010) 0.80
Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry. Int J Cardiol (2013) 0.78
Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients. Ann Noninvasive Electrocardiol (2013) 0.78
Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients. J Am Coll Cardiol (2015) 1.43
Clinical Inferences of Cardiovascular Implantable Electronic Device Analysis at Autopsy. J Am Coll Cardiol (2016) 0.76
Cardiovascular implantable electronic device function and longevity at autopsy: an underestimated resource. Heart Rhythm (2016) 0.75